| cell transformation, neoplastic | Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. (12 Dec 1998) |
|---|
| cell transformation | Morphological and physiological changes resulting from infection of an animal cell by an oncogenic virus. (05 Mar 2000) |
|---|---|
| cell transformation, viral | An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. (12 Dec 1998) |
| gene expression regulation, neoplastic | Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. (12 Dec 1998) |
| pregnancy complications, neoplastic | Neoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease. (12 Dec 1998) |
| neoplastic | <oncology, pathology> Pertaining to or like a neoplasm with new and abnormal growth, pertaining to neoplasia with the formation of a neoplasm. Origin: Gr. Plassein = to form (18 Nov 1997) |
| neoplastic arachnoiditis | Infiltration of subarachnoid space by neoplastic cells, typically medulloblastoma or metastatic carcinoma. Synonym: neoplastic arachnoiditis. (05 Mar 2000) |
| neoplastic endocrine-like syndromes | Endocrine syndromes due to hormone production by neoplasms of non-endocrine tissue, or by other than the usual endocrine tissues. They are often the first indication of a previously undetected neoplasm. (12 Dec 1998) |
| neoplastic meningitis | Infiltration of subarachnoid space by neoplastic cells, typically medulloblastoma or metastatic carcinoma. Synonym: neoplastic arachnoiditis. (05 Mar 2000) |
| neoplastic processes | The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity. (12 Dec 1998) |
| neoplastic syndromes, hereditary | The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumour tends to occur at an earlier than average age, individuals may have more than one primary tumour, the tumours may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance. (12 Dec 1998) |
| abiotic transformation | <biochemistry> An abiotic transformation is any process in which a chemical in the environment is altered by non-biological mechanisms (such as by exposure to sunlight). (09 Oct 1997) |
| bacterial transformation | <microbiology> A genetics lab procedure where bacteria are induced to accept and incorporate into their genome foreign pieces of cell-less, isolated DNA, often in the form of a plasmid. The DNA to be introduced usually contains a selectable marker so that the bacteria which successfully incorporate the DNA can be selected for. (09 Oct 1997) |
| blast transformation | <haematology> The morphological and biochemical changes in lymphocytes, both B and T, on exposure to antigen or to a mitogen. The cells appear to move from G0 to G1 stage of the cell cycle. They usually enlarge and proceed to S phase and mitosis later. The process probably involves receptor cross linking on the plasma membrane. (18 Nov 1997) |
| genetic transformation | <molecular biology> Genetic change brought about by the introduction of exogenous DNA into a cell. See: transformation, germ line transformation, transfection. (18 Nov 1997) |
| germ line transformation | Micro injection of foreign DNA into an early embryo, so that it becomes incorporated into the germ line of the individual and thus stably inherited in subsequent generations of transgenic organisms. Typically, the DNA would be a reporter gene or cDNA in a vector such as a transposon, that might also carry a visible marker gene such as eye or coat colour), so that successful transformation could readily be detected. (18 Nov 1997) |